A new COVID-19 variant, XEC, a sub-lineage of Omicron, has emerged and is causing concern among experts. The variant has been detected in multiple countries, including Europe and the United States, and is exhibiting signs of rapid spread. While symptoms are similar to previous Omicron variants, experts urge vaccination and adherence to hygiene protocols for protection.
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Moderna’s updated COVID-19 vaccine targeting the Omicron variant. The vaccine will be available through the NHS autumn vaccination program and privately for those not eligible. This follows similar approvals in Taiwan and the US for updated COVID-19 vaccines.
India has recorded 324 COVID-19 cases involving the KP.1 and KP.2 sub-variants of the JN1 variant (an offshoot of Omicron), with 290 cases of KP.2 and 34 cases of KP.1. The Indian SARS-CoV-2 Genomics Consortium (INSACOG) reports that there is no associated increase in hospitalizations or severe cases. The mutations are a natural occurrence for viruses like SARS-CoV2. 34 cases of KP.1 have been found across seven states and UTs, with 23 from West Bengal. KP.2 cases have been detected in 12 states and UTs, with Maharashtra reporting the highest (148). INSACOG monitors new variants and samples changes in disease severity. The emergence of these sub-variants in India coincides with a surge in COVID-19 cases in Singapore, where authorities have recommended mask-wearing.
